In the rapidly evolving field of myopia management, 1 of the most asked—and often misunderstood—questions from both parents and clinicians is, when can we stop treatment?
From new conferences and OCT systems to the links between pediatric uveitis and early-onset atopic dermatitis, these are the news stories and studies that caught our attention this week…
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
While these spectacle lenses are not yet approved by the US Food and Drug Administration, it’s likely a nod from the organization is not too far off. As a result, discussing the factors that influence treatment success makes sense.